Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Mevion Medical Systems is a leading provider of compact proton therapy systems for cancer treatment. The company is dedicated to making this advanced radiation therapy technology more accessible to cancer centers and patients worldwide. Their flagship MEVION S250 Series™, including the MEVION S250i with HYPERSCAN® pencil beam scanning and the MEVION S250-FIT™ (Focused Intensity Modulated Therapy), are designed to be smaller, more affordable, and easier to install and operate than traditional multi-room proton therapy systems. Mevion focuses on innovation to enhance precision, reduce treatment times, and improve patient outcomes in radiation oncology.
The headquarters serves as the central hub for research and development, engineering, manufacturing, global sales and marketing, customer support, and corporate operations.
The facility includes advanced manufacturing space for its compact proton therapy systems, R&D labs, and corporate offices. It is designed to support the entire lifecycle of their products, from conception to post-installation support.
Mevion fosters a work culture centered on innovation, collaboration, and a patient-first mindset. Employees are driven by the mission to make proton therapy more accessible and to improve cancer care. The environment encourages problem-solving and technical excellence.
The Littleton headquarters is significant as it represents Mevion's commitment to U.S.-based manufacturing and innovation in the advanced medical device field. Its location near Boston facilitates collaboration with leading medical institutions and research organizations.
Mevion Medical Systems supports a global network of cancer treatment centers. Their functions supported globally include sales and marketing of their proton therapy systems, installation and commissioning, clinical training and support for medical staff, ongoing maintenance and technical service, and research collaborations to advance proton therapy applications.
300 Foster St
Littleton
MA
USA
Address: Contact Mevion for specific European office details.
To provide localized support, expand market presence, and facilitate installations and maintenance of Mevion systems in the EMEA region, working closely with hospitals and cancer treatment centers.
Address: Contact Mevion for specific Asian office details.
To cater to the increasing demand for advanced cancer treatment technologies in Asia, providing regional expertise and customer support.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Mevion Medical Systems' leadership includes:
Mevion Medical Systems has been backed by several prominent investors over the years, including:
Mevion has seen some key leadership appointments in the recent period to strengthen its executive team for future growth and market expansion. Notably, Tao Meng was appointed CEO in early 2024.
Discover the tools Mevion Medical Systems uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Mevion Medical Systems primarily uses the [first_initial][last]@mevion.com email format. This is a common structure for companies in the technology and medical sectors.
flast@mevion.com (e.g. jsmith@mevion.com)
Format
tmeng@mevion.com
Example
90%
Success rate
Mevion Medical Systems Press Release • February 27, 2024
Mevion announced it has received FDA 510(k) clearance for the HYPERSCAN® pencil beam scanning (PBS) technology on its MEVION S250-FIT Proton Therapy System™. This clearance expands the capabilities of the FIT™ system, designed for institutions looking to add or expand proton therapy services with a smaller footprint and lower capital cost....more
Mevion Medical Systems Press Release • November 28, 2023
Mevion announced the successful installation of the first MEVION S250-FIT™ proton therapy system at the University Hospital Carl Gustav Carus Dresden in Germany. This marks a significant milestone for Mevion's expansion in Europe and the adoption of its compact proton therapy solution....more
Mevion Medical Systems Press Release • January 23, 2024
Mevion Medical Systems announced the appointment of Tao Meng as its new Chief Executive Officer. Mr. Meng brings over two decades of leadership experience in the global medical device industry. Tina Tian, who served as interim CEO, will continue in her role as Chairperson of the Board....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Mevion Medical Systems, are just a search away.